Abstract:Objective: To explore the effect of neoadjuvant immunotherapy on pulmonary function and the efficacy in patients with resectable non-small cell lung cancer. Methods: Data of 30 patients with non-small cell lung cancer (NSCLC) who received neoadjuvant immunotherapy before surgery in the Chest Hospital of Shanghai Jiaotong University from March 2018 to September 2021 were retrospectively collect. The efficacy and safety of neoadjuvant immunotherapy in the perioperative period and changes in pulmonary function of patients before and after neoadjuvant treatment were valuated. Results: The patients were all-male with age of (61±8)years old, The major pathological response (MPR) rate of patients receiving neoadjuvant immunotherapy was 43%(13 cases), the pathologic complete response (pCR) rate was 37% (11 cases), disease control rate (DCR) was 97% (29 cases), objective response rate (ORR) was 67% (20 cases). The forced expiratory volume in one second (FEV1) after treatment was (2.59±0.63) L, and the ratio of FEV1 to the predicted value (FEV1%pred) was 85.27%±15.86%, which were significantly higher than those before treatment [(2.48±0.59)L, 81.73%±15.94%, respectively] (P=0.013, 0.022, respectively). Forced vital capacity (FVC) after treatment was (3.59±0.77) L, which was also significantly higher than before [(3.47±0.76) L,P=0.036]; while there were no statistical difference in FEV1/FVC and FVC accounted for the proportion of predicted values (FVC%pred) between before and after treatment (P=0.084, 0.344, respectively). The ratio of carbon monoxide dispersion (DLCO) to the predicted value (DLCO%pred) decreased from 83.61%±13.10% to 78.69%±13.85% after treatment (P=0.023). There was no significant difference in the incidence of postoperative complications between the DLCO%pred decreased group and the non-decreased group (3/18 vs 0/6; P=0.546). Conclusions: Neoadjuvant immunotherapy can increase the rate of MPR and PCR, significantly increase FEV1 and FEV1%pred, but also lead to a decrease in DLCO%pred; neoadjuvant immunotherapy does not increase the incidence of postoperative complications.

The Effect of Neoadjuvant Chemotherapy on Quality of Life in Patients Diagnosed with Local Advanced Non-small Lung Cancer

[Effect of chemotherapy on the quality of life of lung cancer patients]

Effects of Concurrent Chemoradiotherapy and Sequential Radiotherapy and Chemotherapy on Progression-free Survival in Patients with Non-small Cell Lung Cancer

Effects Of Neoadjuvant Chemotherapy On Respiratory Function In Patients With Breast Cancer

Clinical Observation of Neoadjuvant Chemotherapy and Operation for Patients with Non-small Cell Lung Cancer

Effect of neoadjuvant therapy on serum transforming growth factor-β, squamous cell carcinoma associated antigen, and prognosis in patients with locally advanced esophageal cancer

The Impact of Neoadjuvant Chemotherapy and Adjuvant Chemotherapy on NSCLC Supported by Evidence-based Medicine

Survival Study of Neoadjuvant Versus Adjuvant Chemotherapy with Docetaxel Combined Carboplatin in Resectable Stage IB to IIIA Non-Small Lung Cancer.

Effect of Surgery on Quality of Life of Patients with Spinal Metastasis from Non-Small-Cell Lung Cancer

Effect of chemotherapy combined with amino acid on quality of life in elderly patients with non-small cell lung cancer

Clinical effect of neoadjuvant chemotherapy combined with laparoscopic surgery for patients with colorectal cancer

Curative Effect Analysis of Locally Advanced Non-smallCell Lung Cancer with Surgical Treatment

Effect of Neoadjuvant Chemotherapy in Treatment of Locally Advanced Breast Cancer with Cytologically Proven Axillary Node Metastases

[Investigation of Long-Term Outcome for Lung Cancer of Patients with Neoadjuvant Chemotherapy].

The impact of chemotherapy on quality of life in advanced-stage lung cancer patients

Progress of Neoadjuvant Therapy Combined with Surgery in Non-small Cell Lung Cancer

Study for the effect of chemotherapy on the quality of life for young women with lung cancer

Efficacy of Neoadjuvant Regional Arterial Chemotherapy for Patients with Advanced Gastric Cancer

Analysis of Quality of Life and the Related Factors in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Effect of different treatments on the quality of life of endometrial cancer patients

[Impact of Neoadjuvant Immunotherapy on Pulmonary Function and Perioperative Outcomes in Patients with Resectable Non-Small Cell Lung Cancer].